Cleared Traditional

K171731 - KRONUS IA-2 Autoantibody (IA-2Ab) ELISA Kit (FDA 510(k) Clearance)

Jan 2018
Decision
221d
Days
Class 2
Risk

K171731 is an FDA 510(k) clearance for the KRONUS IA-2 Autoantibody (IA-2Ab) ELISA Kit. This device is classified as a Tyrosine Phosphatase (ia-2) Autoantibody Assay (Class II - Special Controls, product code OIF).

Submitted by Kronus, Inc. (Star, US). The FDA issued a Cleared decision on January 19, 2018, 221 days after receiving the submission on June 12, 2017.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 866.5660. The Device Is Used For The Semi-quantitative Determination Of Autoantibodies Against Tyrosine Phosphatase (ia-2) In Human Serum As An Aid In The Diagnosis Of Type 1 Diabetes Mellitus (autoimmune Mediated Diabetes)..

Submission Details

510(k) Number K171731 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 12, 2017
Decision Date January 19, 2018
Days to Decision 221 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement

Device Classification

Product Code OIF - Tyrosine Phosphatase (ia-2) Autoantibody Assay
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.5660
Definition The Device Is Used For The Semi-quantitative Determination Of Autoantibodies Against Tyrosine Phosphatase (ia-2) In Human Serum As An Aid In The Diagnosis Of Type 1 Diabetes Mellitus (autoimmune Mediated Diabetes).